The Head Trauma Market Size was valued at USD 3.77 Billion in 2023. The global head trauma industry is projected to grow from USD 4.16 Billion in 2024 to USD 8.42 Billion by 2032, exhibiting a CAGR of 8.15% during the forecast period (2024 - 2032).
Head trauma is a brain injury that is occurred when there is a minor bump on the skull or serious brain injury.
Head trauma causes traumatic brain injuries, which often happen due to accidents and acts of violence. These activities affect the brain's nerves and lead to trauma.
Other reasons for brain injury are due to strokes and interrupted blood supply to the brain because of blocked arteries or when a blood vessel bursts out. Overdose of drugs or alcohol can also result in brain injury. Even in people with diabetes, which leads to unstable blood sugar levels, such as hyperglycemia or hypoglycemia can affect the brain and lead to head trauma. In today's world, diseases and violent activities affecting the brain are vigorously increasing, driving the Market. After an attack, people with heart problems lack oxygen supply to the brain, and infections such as encephalitis and meningitis cause inflammation of the brain; in severe cases, it can result in brain trauma. The rise in these infections and health problems is propelling the Head Trauma Market Growth.
Exposure to toxins like carbon monoxide causes severe brain damage. The harsh environmental condition due to pollution and other factors leads to greenhouse effects. Toxic gases are released into the environment, affecting the brain's health. These factors are also driving the Market.
The chief growth factors boosting the market are the higher rate of head injuries, heavy investment by biotechnology and pharmaceutical industries in research and development activities, and demand for better treatment, accelerating Head Trauma Market Share. Other factors such as the reimbursement policies and growing application are fueling up the market.
Widespread development in the healthcare sector is propelling the market's demand. The developments of key players and their advanced strategies are helping the Market obtain good value.
On July 2022, DARPA (the Defense Advanced Research Projects Agency of the United States’ Department of Defense) launched a research effort to redefine how brain injuries are diagnosed in war. Intracranial pressure detection without invasive diagnostic testing and specialized surgical procedures is the goal of the DARPA project, which seeks to develop new technologies for this purpose.
Swift Medical Inc. introduced Swift Ray 1, a unique hardware device that can connect wirelessly with Smartphone cameras, in March 2022. This is, among other things, a game-changer in wound care technology, capturing complete clinical data for more efficient wound assessment, monitoring and treatment, as well as other skin challenges. The design of Swift Ray 1 makes it pocket-sized so that a doctor or patient holds it easily; thus, portable medical imaging compatible with convenient placement on the palm becomes possible. This revolutionary technology equips healthcare professionals with portable imaging abilities from a hospital setup to a patient’s home environment.
In February 2022, tiny biosensors developed by Ohio State University researchers were successfully tested in the laboratory to help identify traumatic brain injury-related biomarkers. The chip has field effect transistors, which act like electrical signals after sensing chemicals and these signals can be detected and evaluated out of the body.
BioDirection announced progress in its clinical trials and regulatory milestones towards commercialization in 2022. BioDirection has developed Tbit™ system, which is a point-of-care test for TBI.
This evaluation commenced when scientists at the University of Alabama at Birmingham (UAB) initiated a new non-invasive technique in October 2021, for example. U.S Food and Drug Administration approved it as one method to evaluate “hematoma expansion” within the brain. They had plans at the UAB team to introduce Infrascanner used for brain injury surveillance.
Arkansas Children’s Hospital agreed in August 2021 to acquire TRIUX™ neo, which provides functional brain imaging capacity across various conditions such as epilepsy, brain tumors, traumatic brain injury, post-traumatic stress disorder and Autism Spectrum Disorders for diagnosing patients.
COVID-19 Analysis
During the pandemic period, the Head Trauma Market faced a challenging situation due to the lockdown. The manufacturing units and other industrial units were shut down for a longer period, which affected the market's growth. The market noticed huge revenue loss, which led to disruption of the supply chain. The services couldn't reach the end-users at the necessary time, which decreased the market's demand.
In the further days of the pandemic, the Head Trauma Market recovered its growth when its demand increased. The virus is highly infectious for patients with underlying head trauma conditions, leading to complete brain damage. The higher concern among the public has propelled the market's demand—the growth rate recovered within a limited period. In the post-pandemic period, the market's growth will remain consistent, and it will reach the evaluated value during the forecasted period.
The Head Trauma Market is noticing worldwide growth due to major growth drivers.The rise in demand for minimally invasive neuro procedures for minimal pain, limited cause of infection, and speedy recovery is boosting the market. Other major drivers are the rise in the number of head injuries and higher investment by the pharmaceutical industries and biotechnology organizations in the research and development activities are chiefly driving the market. The growing concern and awareness among the people for treating brain injuries at the earliest stage is another market driver.
The challenging factor is trying to restrict the market's growth. The pandemic was a challenging situation for the market, but it successfully overcame it. The lack of experts and lack of awareness among people for proper brain treatment are other challenging factors.
The growth opportunities are helping the Head Trauma Market emerge globally. The rise in car accidents and sports injuries creates ample opportunities for the market. Moreover, the initiatives and programs undertaken by the governments in various countries about brain injuries are fueling the market's demand. Joint ventures, mergers and acquisitions, strategic alliances, and new product developments among the key players are setting wide opportunities for the market.
The Market facing restraining factors that hamper the growth, such as the lack of availability of facilities and higher treatment costs, are major constraints limiting the Head Trauma Market Value.
Cumulative Evaluation Of The Market
The Market is expected to reach a good valuation due to the presence of growth drivers and opportunities. The challenges and constraints affect progress, but with the player's strategies, the market will successfully overcome them. The pandemic has shown a mixed impact on the market, but its demand remained stable. Hence, the market is estimated to reach a strong value during the forecast period.
The Head Trauma Market Size is segmented into type, diagnosis, treatment and end-user. These major segments are further sub-segmented into different sections. All these sections have a crucial role in the market.
The type segment of the Head Trauma Market has one major type- Hematoma. It is a severe condition where blood gets collected outside of a blood vessel. There are various hematomas such as subdural, spinal, subungual, ear, and hepatic.
The diagnosis segment of the market is categorized into physical examination, brain scans, and CT scans. These are the types of diagnosis through which the severity of the head trauma condition of the patient is known.
The treatment segment of the market is classified into medical treatment, anti-seizure drugs, and surgery. Above are the major treatment procedure to treat head trauma conditions.
The end-user segment of the market consists of hospitals and clinics, and research institutes. The Head Trauma Market is showing tremendous growth in these places due to its wide application.
According to the geographical report, the Head Trauma Market Analysis covers major regions such as the Americas, Europe, Asia Pacific, the Middle East and Africa.
The Americas is noticed as the dominating region of the market due to the availability of well-developed technology, rise in the number of patients suffering from brain disorders, higher health expenditure, and government's support for research and development is driving the regional market. Moreover, the increased rate of research and development activities is fueling the market of this region.
Europe stands in the second position of the market due to the government support in research and development projects, and the availability of funds is driving the regional market. Developed countries such as Germany and France are rising their investment in the healthcare sectors to develop hospital infrastructure.
The Asia Pacific is considered the fastest-growing region due to the presence of developing healthcare technology, changes in lifestyle leading to stressful life, and higher healthcare expenditure. These factors are propelling the market of the APAC region. The demand for quality devices and increased patients in India and South Korea is driving the usage of advanced equipment, which is lifting the regional market.
Other regions such as the Middle East and Africa are holding only the least share due to lack of funds availability, and limited medical facilities are restricting its growth.
Competitive Intensity Within The Industry
The major industrial players are helping the Head Trauma Market to propel at a higher space due to their efforts. The collaborations with the health sector and governments are helping the market to show a significant rate. The players' marketing strategies and other developmental ideas will help the Market reach a good valuation in the forecast period. Their presence in prominent regions and their developments and launches are letting the market score a strong compound annual growth rate. Below are the top players who are pushing higher the Head Trauma Market Trends.
Recent Market Developments
The FDA in February 2021 approved a novel device, which is intended to be worn around the neck for athletes aged above 13 years during games to help protect the brain from repetitive sub-concussive head blows. This is a non-invasive C-shaped collar that compresses the neck, applying pressure and increasing blood volume to minimize movement of the brain inside cranial space after head trauma. Doing this will reduce the risk of specific brain abnormalities associated with brain injury.
After being approved by the US FDA in January 2021, the i-STAT Alinity platform became an instant handheld traumatic brain injury (TBI) blood test gadget.
BrainScope announced its third revolutionary FDA-cleared algorithm for use with the BrainScope device in March 2021. The Concussion Index is the first physiological marker of concussive damage that helps doctors objectively examine patients at baseline, at the moment of injury, and during recovery.
In December 2022, General Dynamics Information Technology (GDIT), a commercial unit of General Dynamics, received an $84 million contract from the Defense Health Agency (DHA) to support the Traumatic Brain Injury Center of Excellence (TBICoE).
BrainScope Company Inc., in August 2022, introduced its first artificial intelligence or AI-based FDA-cleared handheld Class II medical device that recognizes objective biomarkers associated with structural and functional damage caused by concussion and intracranial hemorrhage in patients with suspected mild TBI through an Innovative Technology contract awarded by Vizient, Inc., the nation's largest member-driven health care performance improvement company.
Report Overview
The detailed study of the Head Trauma Market shows its growth at the global level. The market noticed huge growth due to the presence of growth factors. The dynamics of the market are showing their effects. The segmentation reports show the major segments of the market. The regional growth of the market was mentioned along with its drivers. The key role of the players was observed based on their developmental activities. Despite the presence of challenges, the Head Trauma Market is estimated to reach the estimated CAGR during the forecast period.
| Report Attribute/Metric | Details |
| Market Size | USD 8.42 Billion |
| CAGR | 8.15% |
| Base Year | 2023 |
| Forecast Period | 2024-2032 |
| Historical Data | 2022 |
| Forecast Units | Value (USD Billion) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Segments Covered | By Types, Treatment, End User |
| Geographies Covered | North America, Europe, Asia-Pacific, and Rest of the World (RoW) |
| Key Vendors | Fujifilm Holdings (Japan), GE Healthcare (U.S.), Siemens Healthcare(U.S.), Philips Healthcare (U.S.), Shimadzu Corporation (Japan), Toshiba Medical Systems Corporation (Japan), Carestream Health (U.S.), Nihon Kohden Corporation (Japan), Electrical Geodesics Inc. (U.S.), Masimo Corporation (U.S.), Hologic (U.S.), Esaote (Italy) |
| Key Market Opportunities | Joint ventures, strategic alliances, mergers and acquisitions and new product developments |
| Key Market Drivers | · Increasing prevalence of head injuries · Increasing investment by biotechnology and pharmaceutical industries in R&D |
Head Trauma Market Highlights:
Frequently Asked Questions (FAQ) :
The head trauma market CAGR would be 8.15% during the forecast period.
High cost of treatment and lack of facilities can impact the head trauma market.
The Americas would lead the head trauma market.
The Asia Pacific head trauma market would be the fastest-growing market.
Players involved in the head trauma market are GE Healthcare (U.S.), Shimadzu Corporation (Japan), Toshiba Medical Systems Corporation (Japan), Siemens Healthcare(U.S.), Philips Healthcare (U.S.), Fujifilm Holdings (Japan), Electrical Geodesics Inc. (U.S.), Masimo Corporation (U.S.), Hologic (U.S.), Esaote (Italy), Carestream Health (U.S.), Nihon Kohden Corporation (Japan), and others.
Research Analyst Level I He is an extremely curious individual currently working in healthcare and medical devices domain. kinjoll is comfortably versed in data centric research backed by healthcare educational background. he leverages extensive data mining and analytics tools such as primary and secondary research, statistical analysis, machine learning, data modelling. his key role also involves technical sales support, client interaction and project management within the healthcare team. lastly, he showcases extensive affinity towards learning new skills and remain fascinated in implementing them.
Get in Touch
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
